About this trial
Osteoporosis is a progressive disease characterised by a decrease in bone mass, deterioration in bone microarchitecture, and increased fragility. Etiologically, it is divided into two types: primary (postmenopausal and senile) and secondary. Postmenopausal women are particularly at high risk; it is seen in more than 80% of women over the age of 50 and in almost all individuals over the age of 75. With menopause, bone mineral density decreases, which negatively affects neuromuscular functions, leading to balance disorders, decreased walking speed, and an increased risk of falls. Falls are the primary cause of osteoporotic fractures and result in functional loss, morbidity, mortality, and increased healthcare costs. Exercise is effective in reducing bone loss; in recent years, therapeutic virtual reality and exercise games (exergames) have come to the fore. However, the literature on the effectiveness of these applications in postmenopausal osteoporosis patients is limited. The aim of this study is to investigate the effects of virtual reality applications on balance, quality of life, and fall risk and to compare them with a control group.
Eligibility criteria
Qualifiers
Postmenopausal women aged 50-75 years
Individuals diagnosed with osteoporosis based on Dual-Energy X-ray Absorptiometry (DEXA) measurement (T-score ≤ -2.5)
Having been in menopause for at least 1 year
Being able to walk independently (without the use of assistive devices)
Disqualifiers
Secondary osteoporosis diagnosis (e.g. endocrine, metabolic or drug-induced causes)
History of lower limb fracture or surgical intervention within the last 6 months
Individuals with severe cardiovascular, neurological, or musculoskeletal disorders
Individuals with vestibular or visual impairments that may affect balance
Trial design
Treatments tested in this trial
- Conventional treatment
- Virtual reality treatment